Since the early 1980’s, intracavernous pharmacotherapy (ICP) has been rigorously studied by scientists globally. It has proven to be a highly effective ed treatment for erectile dysfunction (ED) and premature ejaculation (PE).
Here are some of the studies that claim ICP’s success in treating men with erection problems:
An Article on the Effective Use of ICP Treatment: Actas Urol Es., 1998
This is an article from the Spanish Association of Urologists about the effective use of ICP in men with erectile dysfunction. The study has led to conclusion that majority of ED cases are the result of the inability of the smooth muscle tissues in the penis to relax. ICP treatment relaxes the smooth muscle tissues in the penis leading to engorgement and thereby creating an erection. Studies show that for more than 15 years of using ICP, it has proven to be over 85% effective in treating men with erectile dysfunction. The article also says that intracavernous pharmacotherapy is safe and reliable in developing men’s sexual health. Alprostadil injection also known as PGE1 is more than 70% safe and effective treatment that improves quality of life of patients. Currently, PGE1 is the drug of choice for impotence with fewer side effects. The article also believes that after the initial administration of ICP treatment, follow up check up is vital. The Boston Medical Group also believes that it is necessary to stand by with our patients throughout their course of treatment.
A Research Paper on ICP for Men with SCI: The Journal of Urology, 1987 Sept.
This research study shows that ICP treatment is highly efficient in achieving erection with spinal cord injury patient. The study included 52 male respondents undergoing intracavernous pharmacotherapy. As a result, all of them were able to achieve erection while 71% of them continued to use ICP on a regular basis.
A Study on Intracavenous Pharmacotherapy against factors resulting in ED; Urology: Official Journal of The International Society of Urology, 1991 May
Erectile dysfunction can either be of a physical or psychological nature. This study conducted by Weiss, Ravalli and Badlani involved the administration of ICP to 20 men who had psychological ED. After treatment, all of them were able to attain successful erection. In fact, all male respondents were proven suitable for self-injection in combination with sex therapy. Also, eight patients had return of spontaneous erections without ICP treatment. Therefore, ICP worked for all men and eight of them were cured of ED.
A Study on the Use of ICP for Impotence: International Journal of Impotence Research, 1998 Dec.
This study found that intracavernous pharmacotherapy was highly successful in treating men with psychological ED. Of the 153 patients included in this study, 98 or 64% needed injection for less than three months while only 18 or 2% reached one year. Therefore, intracavernous self- injection of vasoactive drugs is an effective alternative treatment for men with psychogenic impotence and erectile dysfunction when sex therapy is unsuccessful.
Official Journal of the International Society of Urology
Actas Urol Esp.
US National Library of Medicine
International Journal of Impotence Research